Overview
Matthew Giglio is a Nurse Practitioner in Hackensack, New Jersey. Mr. Giglio is highly rated in 3 conditions, according to our data. His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Non-Muscle Invasive Bladder Cancer, and Muscle Invasive Bladder Cancer.
Graduate Institution
Specialties
Licenses
Board Certifications
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
92 2nd Street, Hackensack, NJ 7601.
Natalia Cherkassky is a Nurse Practitioner in Fair Lawn, New Jersey. Ms. Cherkassky is highly rated in 1 condition, according to our data. Her top area of expertise is ALK-Positive Non-Small Cell Lung Cancer.
Weill Medical College Of Cornell
Karen Pekle is a Nurse Practitioner in New York, New York. Ms. Pekle is highly rated in 2 conditions, according to our data. Her top areas of expertise are Relapsed Refractory Multiple Myeloma (RRMM) and Smoldering Multiple Myeloma.
NY Office
David Mendoza is a Nurse Practitioner in New York, New York. Mr. Mendoza is highly rated in 1 condition, according to our data. His top area of expertise is ALK-Positive Non-Small Cell Lung Cancer.
Frequently Asked Questions about Matthew A. Giglio, NP
How do I make an appointment with Matthew A. Giglio, NP?
You can book an appointment with Matthew A. Giglio, NP by calling their office at 551-996-5901. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Matthew A. Giglio, NP a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Matthew A. Giglio, NP is classified as an Advanced expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Matthew A. Giglio, NP specialize in?
While Matthew A. Giglio, NP is a Nurse Practitioner, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer, Non-Muscle Invasive Bladder Cancer, and Muscle Invasive Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Nurse Practitioner.
Does Matthew A. Giglio, NP accept my insurance?
Matthew A. Giglio, NP accepts most major insurance plans, including Aetna and Change Healthcare. We recommend calling the office directly at 551-996-5901 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Muscle Invasive Bladder CancerMr. Giglio isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder Cancer